Related Experiment Videos
N-acetyltransferase 2 polymorphisms in patients with Behcet's disease
L Tamer1, U Tursen, G Eskandari
1Department of Biochemistry, Mersin University, Turkey. lutamer@yahoo.com
Clinical and Experimental Dermatology
|January 25, 2005
Summary
Genetic variations in N-acetyltransferase (NAT) 2 slow acetylator status may increase susceptibility to Behcet's disease. Specific NAT2 mutations, NAT2*5A and NAT2*6A, were linked to a higher risk of developing this autoimmune condition.
Area of Science:
- Genetics
- Immunology
- Pharmacogenomics
Background:
- Behcet's disease (BD) pathogenesis may involve environmental, genetic, and xenobiotic metabolism factors.
- N-acetyltransferase 2 (NAT2) is a key enzyme in xenobiotic metabolism; its slow acetylator phenotype is theoretically linked to autoimmune mechanisms.
Purpose of the Study:
- To investigate the association between genetic polymorphisms in the NAT2 gene and susceptibility to Behcet's disease.
Main Methods:
- Case-control study involving 40 Behcet's disease patients and 82 controls.
- Genotyping of NAT2*5A, NAT2*6A, NAT2*7A/B, and NAT2*14A polymorphisms using real-time PCR.
Main Results:
- The NAT2*5A genotype showed a significantly increased risk for Behcet's disease (OR = 66.29, 95% CI = 8.21-535.33).
- The NAT2*6A genotype also indicated an elevated risk (OR = 24, 95% CI = 2.04-304.98).
- No increased risk was associated with NAT2*7A/B or NAT2*14A polymorphisms.
Conclusions:
- Slow acetylator status conferred by NAT2 polymorphisms, specifically NAT2*5A and NAT2*6A, may be a determinant factor in Behcet's disease susceptibility.
- These findings contribute to understanding Behcet's disease pathogenesis and may inform therapeutic strategies.